An exciting collaborative project has been made considerably easier by a donation from the Asbestos Diseases Society of Australia (ADSA), which has enabled the purchase of a piece of equipment called a MultiSyn radiosynthesiser. The study uses tracers to predict immunotherapy success in people with mesothelioma; existing similar equipment at SCGH is not set up for Zirconium 89, and, without the MultiSyn, would need to be recalibrated each time. The timeliness and quality of production for patient use is considerably improved by this purchase.

Acting Director of NCARD Professor Richard Lake is flanked by Robert and RoseMarie Vojakovic from ADSA to gratefully accept the donation. Thank you!